In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
101 News Items found
Memorial Sloan Kettering is transforming our understanding and treatment of cancer in a myriad of ways.
Feature
Memorial Sloan Kettering Transforms Cancer Research and Care Delivery

Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.
David Hyman and Robin Gillespie
Finding
#AACR17: Basket Trial for Experimental Drug Shows Promising Early Results

Neratinib, which targets mutations that drive cancer growth, is showing promise for treating several types of cancer.
Gloved hand and magnifying glass on banded DNA sequences
Announcement
FDA Authorizes MSK-IMPACT Test for Analyzing Patient Tumors

The test, developed at MSK, looks for alterations in 468 genes that are seen in both common and rare cancers.
Three sets of PET images
Finding
DeepPET Uses Artificial Intelligence to Generate Images of the Body’s Internal Activities

MSK researchers are developing a new image-generation method for PET scans. It may prove to be quicker and clearer than current scans.
Through-the-microscope view of a tissue sample
MSK Research Highlights, July 17, 2023

New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward improving options for patients with early-stage, potentially indolent cancers.
(From left) David Scheinberg, Andrew Zelenetz, and Joseph Jurcic are using monoclonal antibodies to improve the treatment of patients with leukemia and lymphoma.
Monoclonal Antibody Drugs for Cancer Treatment

Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.
Map of world showing where postdocs came from.
International Postdocs From 60 Countries Are Training at MSK in 2025

What inspires the outstanding young scientists who come from around the world to train at MSK?
Kate Delp standing on the beach, smiling and holding a yoga mat
Finding
Why More People With Breast Cancer Are Choosing Lumpectomy Over Mastectomy: Kate’s Story

An MSK study found a rise in lumpectomies and a decline in mastectomies — reversing a trend that experts say was leading to the overtreatment of breast cancer.
Albert Kuchler discussing his treatment results with MSK oncologist Bob Li at a recent clinic visit.
Feature
For People with a Rare Mouth Cancer, a Targeted Drug Can Be Lifesaving

The drug targets a protein called HER2 found on some salivary gland tumors.
Nurses from the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
MSK Nurses Honored at Robbins Family Awards for Excellence

Meet the winners of the 2022 Robbins Family Awards for Excellence at Memorial Sloan Kettering Cancer Center.